Seques is the first global healthcare communications agency to specialize in the field of genomics. Advances in the understanding of the genetic basis of disease are leading to major developments in the diagnosis and treatment of a wide range of both common and rare disorders. Seques combines expertise in genomics with a global agency platform and extensive experience in healthcare communications. We partner with leading global pharmaceutical, biotech and diagnostic companies to create scientifically accurate and impactful programmes designed to inform healthcare professionals, patients and other stakeholder groups. The Seques brand name and microarray-inspired symbol reinforce our focus on genomic medicine for the management of both common and rare diseases. Seques is an AMICULUM® agency. AMICULUM is an independent global healthcare communications and consulting business with offices in New Zealand, China, Singapore, the UAE, Switzerland, the UK and the USA (www.amiculum.biz).